Healthcare Industry News: total hip replacement
News Release - December 2, 2014
US Medical Innovations, LLC Announces New Distribution Agreement With CrossLink Surgical, LLCTAKOMA PARK, Md., Dec. 2, 2014 -- (Healthcare Sales & Marketing Network) -- US Medical Innovations (USMI), a Takoma Park, M.D. based biomedical device sales and distribution company announced today it has expanded its sales network through a distribution agreement with CrossLink Surgical, a subsidiary of CrossLink Life Sciences, LLC. CrossLink is one of the largest orthopaedic distributors in the U.S. and the top domestic distributor for Stryker joints.
Under the new agreement, CrossLink will begin distribution of the Canady Hybrid Plasma™ Scalpel (CHPS) throughout Alabama, Florida, Georgia, North Carolina and South Carolina. The partnership will further promote USMI's brand and increase market penetration of the CHPS by utilizing CrossLink's talented and experienced sales, operations, and logistics teams, all of whom are leaders in the orthopaedic industry with an extensive and effective track record of introducing new products that not only serve evolving market demands, but help surgeons improve patient outcomes.
The CHPS is the first multifunctional electrosurgical handpiece in the world. Due to its advanced technology, surgeons are able to simultaneously cut and coagulate through biological tissue at a temperature of less than 98°F, significantly reducing intraoperative blood loss and operative time, improving wound healing, minimizing the length of stay for the patient and reducing the risk of hospital acquired infections.
"Crosslink is an experienced group who will provide a much broader reach for USMI and accelerate the introduction of our product to highly visible healthcare professionals throughout the U.S.," said Jerome Canady, MD, CEO & Chief Science Officer of USMI. "The CHP Scalpel's diversity in clinical applications in orthopaedic surgery range from total hip replacement and arthoplasty, tourniquetless total knee replacement, hip and orthopaedic trauma, however the device also provides significant benefits for all clinical subspecialties."
CrossLink Surgical is focused on bringing innovative technologies to "niche" orthopaedic markets and healthcare providers. Its parent company, CrossLink Life Sciences, LLC has a comprehensive orthopaedic sales force serving all hospitals throughout the southeast.
About US Medical Innovations
US Medical Innovations, LLC (USMI) is a private FDA registered U.S. biomedical sales & distribution company founded by transplant surgeon and inventor, Dr. Jerome Canady. USMI's focus is developing advanced, innovative and affordable true plasma electrosurgical devices. The company's products are designed for ambulatory and inpatient endoscopy centers as well as complex surgical procedures.
About CrossLink Life Sciences
CrossLink Life Sciences, LLC is one of the largest orthopaedic and spine device distributorships in the United States. Over the past 35 years CrossLink has built a world class specialty sales organization, formed lasting partnerships with the world's foremost medical device innovators, and provided superior service to world renowned healthcare providers with a foundational goal of improving patient outcomes.
Source: US Medical Innovations
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.